23andme.org
Cure8 news brief
Why This Matters
Genetic testing can help identify both rare high-impact variants and a person’s polygenic risk, which may affect screening discussions and family risk awareness. For people with a family history or ancestry-related risk, these reports can point to questions to bring to a clinician.
Who Should Pay Attention
Adults interested in genetic risk for cancer, people with a family history of prostate or related cancers, clinicians who counsel patients about genetic testing, and patients curious about polygenic risk scores.
Study Snapshot
Story typePatient Advocacy
Evidence typePatient Education
Source depthFull source text
What To Know
This 23andMe blog post explains how DNA influences prostate cancer risk, contrasting rare high-impact variants (like HOXB13 G84E and some BRCA variants) with the cumulative effect of many common variants summarized in a polygenic risk score.
It describes which 23andMe genetic reports are available to customers and notes ancestry-related limitations in risk models.
The piece frames genetic results as information to share with clinicians and family members, and it emphasizes that risk scores and single-variant findings can inform conversations about screening rather than provide definitive diagnoses.
Keep In Mind
23andMe is a direct-to-consumer genetics company; the article explains its specific product reports and their limits. Polygenic scores and many variant associations were discovered mainly in people of European ancestry and may be less predictive for others. Discuss results with a healthcare provider.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publication23andme.org
Indexed viaGoogle News
Source typeWeb article
PublishedSep 23, 2026, 4:22 PM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Crohn’s Disease: Is It in Your Genes?
Genetics can influence Crohn’s disease risk; knowing about risk genes and testing options may help people with a family history understand why disease runs in families and what testing can — and cannot — tell you. The...
Polygenic Risk Scores Show Distinct Genetic Architectures of IBD-Associated Comorbidities.
Shows which IBD comorbidities may be driven in part by shared inherited genetic risk and which likely reflect non-genetic factors, information that could shape future risk stratification and screening approaches for...
Impact of Amerindian ancestry on clinical outcomes in Crohn's disease and ulcerative colitis ...
Genetic ancestry can influence IBD risk and disease course, and most prior studies focused on European populations.